Dr. Francesca Polverino, MD PHD
Pulmonology (Pulmonary Disease Physician)
At a glance
- Years since graduation
- 20
- In the NPI registry since
- 2021
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2021Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
TX license 49268 · TX license 48169 · TX license 47790 · TX license 735407 · TX license 48514 · TX license 48856
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Harris Health Houston, TX
Medical groups
- Baylor College of Medicine (809 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Houston, TX | 39 |
| Incruse Ellipta (umeclidinium bromide) Other prescribers in Houston, TX | 33 |
| Dupixent Syringe (dupilumab) Other prescribers in Houston, TX | 13 |
| Fluticasone Propionate Other prescribers in Houston, TX | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 29 payments worth $27,246 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $13,854 |
|---|---|
| Genzyme Corporation | $13,184 |
| Polarean, Inc. | $87.74 |
| Genentech, Inc. | $55.97 |
| Regeneron Healthcare Solutions, Inc. | $36.55 |
| Verona Pharma, Inc. | $27.17 |
| Consulting Fee | $22,370 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $2,598 |
| Travel and Lodging | $1,300 |
| Food and Beverage | $978 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Nov 24, 2025 | Consulting Fee | $9,750 |
| AstraZeneca Pharmaceuticals LP Jan 4, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $4,028 |
| Genzyme Corporation Mar 31, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $2,598 |
| AstraZeneca Pharmaceuticals LP Sep 22, 2025 | Consulting Fee FASENRA · Respiratory | $2,148 |
| AstraZeneca Pharmaceuticals LP Sep 23, 2025 | Consulting Fee BREZTRI · Respiratory | $2,148 |
| AstraZeneca Pharmaceuticals LP Sep 19, 2025 | Consulting Fee | $2,148 |
| AstraZeneca Pharmaceuticals LP Oct 21, 2025 | Consulting Fee FASENRA · Respiratory | $1,611 |
| Genzyme Corporation Dec 17, 2025 | Travel and Lodging travel to Philadelphia, PA | $597 |
| AstraZeneca Pharmaceuticals LP Aug 27, 2025 | Consulting Fee FASENRA · Respiratory | $537 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $284 |
All 12 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Dec 17, 2025 | Travel and Lodging travel to Philadelphia, PA | $597 |
| Genzyme Corporation Nov 24, 2025 | Consulting Fee | $9,750 |
| AstraZeneca Pharmaceuticals LP Oct 21, 2025 | Consulting Fee FASENRA · Respiratory | $1,611 |
| AstraZeneca Pharmaceuticals LP Sep 23, 2025 | Consulting Fee BREZTRI · Respiratory | $2,148 |
| AstraZeneca Pharmaceuticals LP Sep 22, 2025 | Consulting Fee FASENRA · Respiratory | $2,148 |
| AstraZeneca Pharmaceuticals LP Sep 19, 2025 | Consulting Fee | $2,148 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $284 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $253 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $166 |
| AstraZeneca Pharmaceuticals LP Aug 27, 2025 | Consulting Fee FASENRA · Respiratory | $537 |
| Genzyme Corporation Mar 31, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $2,598 |
| AstraZeneca Pharmaceuticals LP Jan 4, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $4,028 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.